JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2076
Fidelity MSCI Health Care Index ETF
FHLC
$3.42B
| $15.2M | ﹤0.01% |
217,674
+27,825
| +15% | +$1.88M |
2017 Q3
26 quarters
|
|
2077
CALL
Danaher
DHR
$156B
| $15.2M | ﹤0.01% |
60,800
-253,800
| -81% | -$61.9M |
2023 Q3
2 quarters
|
|
|
GAP
2078
The Gap Inc
GAP
$8.18B
| $15.2M | ﹤0.01% |
550,938
-753,632
| -58% | -$15.9M |
2013 Q2
43 quarters
|
|
2079
PUT
Constellation Brands
STZ
$19.4B
| $15.2M | ﹤0.01% |
55,800
-3,500
| -6% | -$886K |
2021 Q3
10 quarters
|
|
2080
MacroGenics
MGNX
$240M
| $15.1M | ﹤0.01% |
1,029,049
-105,695
| -9% | -$1.6M |
2013 Q4
41 quarters
|
|
2081
iShares Silver Trust
SLV
$29.7B
| $15.1M | ﹤0.01% |
665,681
-973,571
| -59% | -$20.8M |
2013 Q2
43 quarters
|
|
2082
iShares Russell Top 200 Value ETF
IWX
$3.68B
| $15.1M | ﹤0.01% |
197,883
-5,822
| -3% | -$421K |
2021 Q1
12 quarters
|
|
2083
International Seaways
INSW
$5.78B
| $15.1M | ﹤0.01% |
283,132
-45,223
| -14% | -$2.34M |
2016 Q4
29 quarters
|
|
2084
Applied Finance Valuation Large Cap ETF
VSLU
$573M
| $15.1M | ﹤0.01% |
462,020
+89,958
| +24% | +$2.8M |
2023 Q3
2 quarters
|
|
2085
CALL
Dynatrace
DT
$17.4B
| $15M | ﹤0.01% |
+323,500
| New | +$16.8M |
2024 Q1
0 quarters
|
|
2086
PUT
Alnylam Pharmaceuticals
ALNY
$29.4B
| $15M | ﹤0.01% |
100,500
+37,700
| +60% | +$6.29M |
2022 Q4
5 quarters
|
|
2087
SharkNinja
SN
$25.7B
| $15M | ﹤0.01% |
241,056
-9,576
| -4% | -$507K |
2023 Q3
2 quarters
|
|
2088
CALL
Occidental Petroleum
OXY
$58.3B
| $15M | ﹤0.01% |
230,800
+47,900
| +26% | +$2.86M |
2022 Q3
6 quarters
|
|
2089
MDU Resources
MDU
$3.93B
| $15M | ﹤0.01% |
1,073,230
-121,821
| -10% | -$1.41M |
2013 Q2
43 quarters
|
|
2090
Nelnet
NNI
$4.47B
| $15M | ﹤0.01% |
157,980
-18,461
| -10% | -$1.62M |
2013 Q2
43 quarters
|
|
2091
AZZ Inc
AZZ
$4.18B
| $14.9M | ﹤0.01% |
193,299
-9,032
| -4% | -$610K |
2014 Q4
37 quarters
|
|
2092
Intellia Therapeutics
NTLA
$1.79B
| $14.9M | ﹤0.01% |
543,107
-93,010
| -15% | -$2.58M |
2017 Q4
25 quarters
|
|
2093
CALL
Elevance Health
ELV
$85.6B
| $14.9M | ﹤0.01% |
28,800
+18,500
| +180% | +$9.2M |
2021 Q3
10 quarters
|
|
2094
SLM Corp
SLM
$4.28B
| $14.9M | ﹤0.01% |
685,256
+73,207
| +12% | +$1.46M |
2013 Q2
43 quarters
|
|
2095
Dimensional International Value ETF
DFIV
$21.6B
| $14.9M | ﹤0.01% |
405,354
-17,561
| -4% | -$609K |
2022 Q4
5 quarters
|
|
2096
First Trust Cloud Computing ETF
SKYY
$3.45B
| $14.9M | ﹤0.01% |
155,588
+8,953
| +6% | +$826K |
2015 Q4
33 quarters
|
|
2097
Evertec
EVTC
$1.74B
| $14.8M | ﹤0.01% |
371,808
-132,448
| -26% | -$5.22M |
2013 Q2
43 quarters
|
|
2098
PUT
Thermo Fisher Scientific
TMO
$250B
| $14.8M | ﹤0.01% |
25,500
+500
| +2% | +$281K |
2021 Q2
11 quarters
|
|
2099
Madrigal Pharmaceuticals
MDGL
$11.4B
| $14.8M | ﹤0.01% |
55,404
-3,909
| -7% | -$921K |
2017 Q3
26 quarters
|
|
2100
Houlihan Lokey
HLI
$8.87B
| $14.8M | ﹤0.01% |
115,322
+5,986
| +5% | +$741K |
2015 Q4
33 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.